IS THERE A RELATIONSHIP BETWEEN SERUM IGF-1 AND THYROID NODULE, THYROID OR OVARIAN VOLUME IN POLYCYSTIC OVARIAN SYNDROME?

Topaloglu O., Evren B., Uzun M., Yologlu S., Guldogan E., Sahin I.

ACTA ENDOCRINOLOGICA-BUCHAREST, vol.17, no.1, pp.138-146, 2021 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 17 Issue: 1
  • Publication Date: 2021
  • Doi Number: 10.4183/aeb.2021.138
  • Journal Name: ACTA ENDOCRINOLOGICA-BUCHAREST
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, EMBASE
  • Page Numbers: pp.138-146
  • Keywords: polycystic ovarian syndrome, IGF 1, thyroid nodule, PCOS, ovarian volume, thyroid volume, GROWTH-FACTOR-I, INSULIN-RESISTANCE, METABOLIC SYNDROME, RISK-FACTOR, PREVALENCE, WOMEN, ASSOCIATION, DISORDERS, PCOS, FEATURES
  • Dokuz Eylül University Affiliated: Yes

Abstract

Context. Studies investigating the association between serum IGF-1, and thyroid nodule, ovarian or thyroid volume in polycystic ovarian syndrome (PCOS) are limited.